X0609 4 2026-10-01 0001640428 EverQuote, Inc. EVER 0001744403 Mendal Jayme false C/O EVERQUOTE, INC. 141 PORTLAND STREET CAMBRIDGE MA 02139 true true false false CEO and President true Class A Common Stock 2026-10-01 4 F false 23757 19.98 D 567403 D Class A Common Stock 2026-10-01 4 M false 11405 0 A 578808 D Class A Common Stock 2026-10-01 4 S false 20633 19.68 D 558175 D Class A Common Stock 2026-10-01 4 S false 347 20.50 D 557828 D Stock Option (right to buy) 6.96 2026-10-01 4 M false 11405 6.96 D 2027-10-17 Class A Common Stock 11405 103069 D Represents shares of Class A Common Stock withheld by the Company to satisfy tax withholding obligations in connection with the net issuance of shares of Class A Common Stock delivered to the Reporting Person on October 1, 2026, upon the vesting of restricted stock units granted on February 17, 2023, February 12, 2024, February 11, 2025 and February 12, 2026, and performance-based restricted stock units granted on February 12, 2024 and February 11, 2025. The number of shares withheld by the Company to satisfy tax withholding obligations (and the net issuance) is based on the closing price of the Company's Class A Common Stock on October 1, 2026. The option exercises and sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.49 to $20.46, inclusive. The reporting person undertakes to provide EverQuote, Inc., any security holder of EverQuote, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.50 to $20.51, inclusive. The reporting person undertakes to provide EverQuote, Inc., any security holder of EverQuote, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. This option was granted on October 18, 2017. 25% of the shares underlying the option vested on September 30, 2018, with the remaining shares vesting monthly thereafter over the following three years. /s/ Jon Ayotte, as attorney-in-fact for Jayme Mendal 2026-10-05